ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the 'Class Period'), of the important August 25, 2025 lead plaintiff deadline.
SO WHAT: If you purchased Sarepta securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Sarepta class action, go to https://rosenlegal.com/submit-form/?case_id=20094 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 25, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) ELEVIDYS, a prescription gene therapy intended for certain patients being treated for Duchenne muscular dystrophy, posed significant safety risks to patients; (2) ELEVIDYS trial regimes and protocols failed to detect severe side effects; (3) the severity of adverse events from ELEVIDYS treatment would cause Sarepta to halt recruitment and dosing in ELEVIDYS trials, attract regulatory scrutiny, and create greater risk around the therapy's present and expanded approvals; and (4) as a result of the foregoing, defendants materially misled with, and/or lacked a reasonable basis for, their positive statements. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Sarepta class action, go to https://rosenlegal.com/submit-form/?case_id=20094 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
——————————-
Contact Information:
Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Market to Reach $10.2 Billion by 2030 - Surge in Awareness Campaigns on Early Cancer Detection Supports Growth
The Radiation Oncology market is propelled by advancements in precise, innovative therapies like IMRT and proton therapy, driven by rising global cancer incidences. Growing AI integration, personalized oncology, and adaptive radiotherapy enhance treatment efficacy. Emerging markets and infrastructure investments offer key growth opportunities. Radiation Oncology Market Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "Radiation Oncology - Global Strategic Business Report" report has been added to global market for Radiation Oncology was estimated at US$7.9 Billion in 2024 and is projected to reach US$10.2 Billion by 2030, growing at a CAGR of 4.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The growth in the radiation oncology market is driven by several factors, including the global rise in cancer prevalence, advancements in radiotherapy technologies, and increasing healthcare investments in oncology infrastructure. Rising incidence of complex and treatment-resistant cancers is propelling demand for precision-focused modalities like proton therapy and stereotactic radiotherapy. At the same time, technological convergence between AI, imaging, and radiotherapy is facilitating personalized treatment planning and outcome monitoring, which enhances clinical effectiveness and operational funding and public-private partnerships are accelerating the deployment of radiotherapy infrastructure in both developed and emerging regions. Additionally, expanding insurance coverage for advanced radiotherapy procedures and increasing awareness about early cancer detection are supporting treatment uptake. Ongoing clinical trials exploring novel combinations of immunotherapy with radiation are expected to open new therapeutic frontiers in the years ahead. Together, these drivers are positioning radiation oncology not only as a cornerstone of modern cancer therapy but also as a field undergoing continuous technological and clinical innovation, with strong growth prospects globally. How Is Radiation Oncology Evolving in Response to Cancer Care Demands?Radiation oncology continues to be a cornerstone in the multidisciplinary management of cancer, with ongoing innovations enhancing both efficacy and precision in targeting malignant tissues. The field has shifted significantly from conventional radiotherapy to highly advanced techniques such as intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), image-guided radiation therapy (IGRT), and proton beam therapy. These modalities allow for accurate dose delivery that spares surrounding healthy tissue, reduces side effects, and improves patient outcomes. Growing cancer incidence worldwide, coupled with an aging population, is pushing healthcare systems to expand radiation oncology infrastructure and adoption of personalized oncology, where treatment is tailored based on tumor genetics and radiomic data, is further redefining treatment planning. Integration of artificial intelligence and machine learning algorithms into radiation oncology software is facilitating adaptive radiotherapy, which adjusts treatment in real time based on patient response and anatomical changes. Additionally, advancements in radiobiology and hypofractionation protocols are enabling shorter treatment durations with equal or improved efficacy, enhancing both throughput and patient convenience. These developments are driving clinical and operational transformation in radiation oncology centers Technologies and Modalities Are Shaping Modern Radiation Oncology Practice?Cutting-edge technologies are transforming the landscape of radiation oncology, with linear accelerators (LINACs), proton therapy units, brachytherapy equipment, and robotic radiosurgery platforms gaining prominence. LINAC systems now incorporate multi-leaf collimators (MLCs), volumetric modulated arc therapy (VMAT), and onboard imaging to deliver precise tumor targeting in fewer sessions. Proton therapy, which deposits most of its energy at the Bragg peak, is witnessing rapid adoption in pediatric oncology and complex tumor cases due to its minimal collateral damage and reduced long-term motion management techniques such as respiratory gating and real-time tumor tracking are being incorporated to address organ movement during therapy, particularly in lung and gastrointestinal cancers. Brachytherapy is gaining renewed interest for cervical, prostate, and breast cancers, thanks to its high dose localization and shortened treatment duration. Integration of MRI and PET imaging into planning systems enhances tumor delineation and adaptive treatment planning. Additionally, emerging radiopharmaceuticals in targeted radionuclide therapy are expanding treatment options for metastatic cancers, particularly in prostate and neuroendocrine Are Hospitals and Cancer Centers Adapting to the Radiation Oncology Revolution?Radiation oncology departments are undergoing significant upgrades to accommodate new technologies, workflow automation, and multidisciplinary integration. Hospitals are investing in hybrid operating suites, advanced treatment planning software, and oncology information systems (OIS) to streamline patient data management and outcome tracking. Additionally, collaborations between radiation oncologists, medical physicists, dosimetrists, and IT professionals are being formalized into cross-functional teams to optimize treatment planning and delivery. Academic medical centers are leading the charge in deploying AI-guided adaptive planning tools and cloud-based contouring platforms that enhance precision while reducing planning and workforce development are also critical components of adaptation. The complexity of modern radiotherapy requires constant upskilling in areas such as image interpretation, machine calibration, and cybersecurity for networked oncology systems. Moreover, hospitals are adopting patient-centered models that integrate psychosocial support, symptom tracking, and remote consultations into radiation oncology care pathways. Global oncology networks and tele-radiation platforms are helping extend advanced radiotherapy services to underserved regions, reducing disparities in cancer treatment access. These operational and clinical upgrades are central to radiation oncology's evolution from a procedural specialty into a fully integrated, data-driven care model. Why You Should Buy This Report: Detailed Market Analysis: Access a thorough analysis of the Global Radiation Oncology Market, covering all major geographic regions and market segments. Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies. Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Radiation Oncology Market. Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions. Key Insights: Market Growth: Understand the significant growth trajectory of the External Beam Radiation Therapy segment, which is expected to reach US$3.6 Billion by 2030 with a CAGR of a 3.3%. The Brachytherapy segment is also set to grow at 5.5% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, estimated at $2.2 Billion in 2024, and China, forecasted to grow at an impressive 7.6% CAGR to reach $2.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Accuray Incorporated, Bionix Radiation Therapy, LLC, Brainlab AG, Canon Medical Systems Corporation, Curium and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Scope of Study: Treatment Type (External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy, Stereotactic Radiosurgery) Technology (Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology, Tomotherapy Technology) Application (Breast Cancer Application, Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application) End-Use (Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use, Ambulatory Surgery Centers End-Use) Key Attributes: Report Attribute Details No. of Pages 488 Forecast Period 2024 - 2030 Estimated Market Value in 2024 7.9 Billion Forecasted Market Value by 2030 10.2 Billion Compound Annual Growth Rate 4.3% Regions Covered Global Key Topics Covered: MARKET OVERVIEW Influencer Market Insights World Market Trajectories Tariff Impact on Global Supply Chain Patterns Radiation Oncology - Global Key Competitors Percentage Market Share in 2025 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E) MARKET TRENDS & DRIVERS Rising Cancer Incidence Worldwide Throws the Spotlight on Advanced Radiotherapy Modalities Technological Advancements in Image-Guided Radiation Therapy Strengthen Precision Treatment Capabilities Expansion of Linear Accelerator Installations in Emerging Markets Drives Equipment Uptake Integration of Artificial Intelligence in Treatment Planning Accelerates Adoption of Adaptive Therapy Solutions Rising Utilization of Stereotactic Radiosurgery Expands Clinical Applications in Brain and Spine Tumors Growth in Proton and Heavy Ion Therapy Centers Drives Demand for High-End Oncology Infrastructure Collaborations Between Research Institutions and Hospitals Fuel Personalized Oncology Approaches Favorable Reimbursement Policies for Radiation Oncology Procedures Sustain Market Accessibility Growing Adoption of Hypofractionated Radiotherapy Enhances Patient Convenience and Throughput Emergence of Real-Time Tumor Tracking and Motion Management Improves Clinical Outcomes Rising Investments in Hybrid Radiotherapy Systems Strengthen Business Case for Multi-Modality Platforms Expansion of Cancer Care Networks and Outreach Programs Boosts Regional Equipment Penetration Increased Focus on Pediatric Radiation Safety Drives Innovation in Dose Optimization Tools Partnerships With Academic Medical Centers Accelerate Development of Evidence-Based Protocols Government Grants for Cancer Treatment Infrastructure Upgrade Promote Public Hospital Modernization Shift Toward Outpatient Radiotherapy Centers Enhances Equipment Turnaround and Affordability Development of Cloud-Based Treatment Planning Systems Improves Workflow and Collaboration Integration of Immunotherapy and Radiotherapy Approaches Strengthens Clinical Trial Pipelines Surge in Awareness Campaigns on Early Cancer Detection Supports Radiation Oncology Growth AI-Enabled Radiomics and Predictive Modeling Drive Precision Medicine in Radiation Treatment FOCUS ON SELECT PLAYERS |Some of the 44 companies featured in this Radiation Oncology market report include: Accuray Incorporated Bionix Radiation Therapy, LLC Brainlab AG Canon Medical Systems Corporation Curium Eckert & Ziegler BEBIG Elekta AB GE Healthcare Hitachi Ltd. IBA (Ion Beam Applications SA) Isoray Inc. Mevion Medical Systems Inc. Nanobiotix Nordion Inc. Optivus Proton Therapy Inc. Panacea Medical Technologies Pvt. Ltd. RefleXion Medical RaySearch Laboratories AB Siemens Healthineers AG Sirtex Medical Limited Varian Medical Systems (Siemens) ViewRay Technologies, Inc. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Radiation Oncology Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Yahoo
35 minutes ago
- Yahoo
S&P 500 Notches New Record, Nasdaq Snaps 6-Day Winning Streak
The S&P 500 advanced to a new high at close on Tuesday, while the Nasdaq Composite registered its fi
Yahoo
an hour ago
- Yahoo
Digital Giants Such as Google, Meta, Amazon, and TikTok Reshape Ad Spending as Retail Media, CTV, and DOOH Lead Emerging Trends
Key market opportunities in online advertising include expanding targeted reach and real-time performance tracking across digital platforms. The shift towards mobile, social media, and streaming content drives increased ad spending. Innovations in AI, programmatic ads, and data analytics enhance personalization and engagement, while privacy regulations propel new targeting strategies. Online Advertising Market Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "Online Advertising - Global Strategic Business Report" report has been added to global market for Online Advertising was estimated at US$219.1 Billion in 2024 and is projected to reach US$352.3 Billion by 2030, growing at a CAGR of 8.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Online Advertising market. Growth in the online advertising market is driven by several factors. Rapid digitization of consumer behavior and media consumption is expanding available ad inventory across mobile, video, and social platforms. Advancements in automation, analytics, and personalization technologies are enhancing campaign effectiveness and operational efficiency. Increased use of e-commerce and digital services is pushing brands to compete for online visibility and conversion. Regulatory shifts and privacy concerns are spurring innovation in ethical data practices and ad delivery models. Additionally, growing investment from small and medium enterprises, facilitated by self-serve ad platforms and affordable pricing models, is expanding market participation. These factors collectively support the sustained evolution and expansion of online advertising as a dominant force in the global marketing Online Advertising Continues to Dominate Global Marketing Strategies?Online advertising has become a cornerstone of modern marketing, offering targeted reach, real-time performance tracking, and high scalability across digital platforms. As consumers increasingly shift toward mobile devices, social media, and streaming content, businesses are allocating larger shares of their budgets to online channels. Unlike traditional media, online advertising enables precision targeting based on user behavior, demographics, interests, and location, making campaigns more efficient and broad spectrum of digital ad formats-such as display ads, video ads, native content, paid search, and influencer marketing-allows brands to engage users at multiple touchpoints. E-commerce growth, digital media consumption, and the rise of app-based services have further expanded advertising inventory across platforms. With its cost-effectiveness, performance-based pricing models, and data-driven optimization, online advertising continues to outpace conventional channels in both reach and return on Are Technologies and Data Analytics Transforming Online Ad Ecosystems?Technological innovation is driving significant transformation in how online ads are created, delivered, and optimized. Programmatic advertising, which uses automated platforms and real-time bidding (RTB), has streamlined media buying and improved ad targeting efficiency. Artificial intelligence and machine learning algorithms are being used to personalize ad content, forecast campaign performance, and identify high-converting analytics tools provide advertisers with granular insights into user engagement, click-through rates, and conversion paths, enabling continuous campaign refinement. Dynamic ad serving technologies customize messages in real-time based on context, such as user location, time of day, or device. Additionally, augmented reality (AR), interactive video, and shoppable content are enriching the user experience and driving higher interaction rates. These developments are making digital campaigns more responsive, immersive, and Market Shifts Are Reshaping Online Advertising Strategies?The shift away from third-party cookies and growing privacy regulations are prompting advertisers to rethink data collection and targeting methods. Platforms are transitioning to privacy-compliant frameworks, emphasizing first-party data, contextual advertising, and consent-based personalization. Apple`s App Tracking Transparency and Google's planned cookie phaseout are accelerating adoption of alternative identity solutions and clean-room the dominance of digital platforms such as Google, Meta, Amazon, and TikTok continues to influence ad spending patterns. Retail media networks, connected TV (CTV), and digital out-of-home (DOOH) advertising are emerging as fast-growing segments, offering brands new avenues to reach audiences across devices and locations. In response to ad fatigue and banner blindness, marketers are investing more in branded content, influencer partnerships, and user-generated content to maintain engagement and authenticity. Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Adobe Inc., Inc., Alphabet Inc. (Google Ads/YouTube), Baidu, Inc., Criteo S.A. and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Key Insights: Market Growth: Understand the significant growth trajectory of the Social Media Advertising segment, which is expected to reach US$94.3 Billion by 2030 with a CAGR of a 10.6%. The Search Engine Advertising & PPC segment is also set to grow at 5.8% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, estimated at $59.7 Billion in 2024, and China, forecasted to grow at an impressive 13.2% CAGR to reach $77.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Scope Of Study: Ad Format (Social Media Advertising, Search Engine Advertising & PPC, Email Marketing, Display Advertising, Native Advertising, Other Ad Formats) Platform (Mobile Advertising, Web / Desktop Advertising) Vertical (Automotive Vertical, Healthcare & Medical Vertical, Retail & CPG Vertical, Education Vertical, BFSI Vertical, Telecom Vertical, Other Verticals) Key Attributes: Report Attribute Details No. of Pages 393 Forecast Period 2024 - 2030 Estimated Market Value in 2024 219.1 Billion Forecasted Market Value by 2030 352.3 Billion Compound Annual Growth Rate 8.2% Regions Covered Global MARKET OVERVIEW Influencer Market Insights World Market Trajectories Tariff Impact on Global Supply Chain Patterns Online Advertising - Global Key Competitors Percentage Market Share in 2025 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E) MARKET TRENDS & DRIVERS Shift Toward Digital-First Marketing Strategies Propels Growth in Online Advertising Budgets Across Industries Rising Penetration of Mobile Devices and Apps Expands Addressable Market for Mobile-Optimized Ad Formats Increased Use of Programmatic Advertising Platforms Drives Automation and Real-Time Bidding Efficiency Growth in Social Media Engagement Strengthens Business Case for Influencer Marketing and Native Ads Integration of AI and Machine Learning Enhances Targeting Accuracy and Personalization in Ad Campaigns Stricter Data Privacy Regulations Throw Spotlight on First-Party Data Strategies and Consent-Based Targeting Emergence of Retail Media Networks and E-Commerce Advertising Generates New Revenue Streams for Brands Adoption of Video-Based Content on Streaming Platforms Spurs Demand for Dynamic and Interactive Video Ads Decline in Traditional TV Viewership Accelerates Brand Shifts to Connected TV (CTV) and OTT Advertising Expansion of Voice Search and Smart Devices Creates Opportunities for Contextual and Audio Advertising Formats Widespread Use of Analytics and Attribution Tools Strengthens ROI Tracking and Campaign Optimization Rising Digital Ad Fraud Risks Encourage Investment in Verification Tools and Ad Quality Control Integration of Augmented Reality and Immersive Experiences Enhances Engagement in Online Ad Campaigns FOCUS ON SELECT PLAYERS |Some of the 42 companies featured in this Online Advertising market report Adobe Inc. Inc. Alphabet Inc. (Google Ads/YouTube) Baidu, Inc. Criteo S.A. Dentsu Group Inc. Havas Group IAC / InterActiveCorp Integral Ad Science (IAS) Microsoft Advertising Omnicom Group Inc. Outbrain Inc. PubMatic Inc. Quantcast Rubicon Project Snap Inc. Taboola, Inc. The Trade Desk, Inc. Yahoo (Verizon Media) Zeta Global For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Online Advertising Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
